In an anticipated decision, released late on Friday April 7, 2023 of the Easter weekend, Texas District Court Judge Kacsmaryk has halted the FDA's approval of Mifepristone.
In January, 2021, the Biden Administration issued Executive Order 13990 ("EO") which re-established an interagency working group (the "Working Group").